FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2525304625> ?p ?o ?g. }

• W2525304625 endingPage "747" @default.
• W2525304625 startingPage "739" @default.
• W2525304625 abstract "In the current study, 5-FU-loaded nanoparticles (NPs) were prepared using polylactic-co-glycolic acid (PLGA), polycaprolactone (PCL), di-block poly lactide-co-caprolactone (PLCL) and tri-block poly L-lactide-co-caprolactone-co-glycolide (PLCLG). The influence of these polymers on the particle sizes, morphology, drug loading, and in vitro drug release was investigated. The anticancer activity was assessed utilizing MTT assay in three human cancer cell lines of different tissue origin; brain (Daoy), liver (HepG2), and colorectal (HT29) using suitable negative and positive controls. The prepared NPs showed a uniform spherical shape with an average size range of 193.5± 6.3 to 303.5± 3.3 nm with negative zeta potential. The entrapment efficiency achieved with F4-F6 (block copolymer NPs) was 78-79% and significantly higher compared with F1 PLGA (31%) and F2; PCL (37%). An initial rapid 5-FU release followed by a slow release ranging from 35% to 81% after 72 h was observed. All the prepared NPs formulations showed enhancement in the cytotoxicity of 5-FU towards all the three cancer cell lines. Generally, block copolymer NPs (F4-F6) showed higher % cell death over PLGA (F1) and PCL (F2) NPs after 48 and 72 h incubation in the case of HepG2 and HT-29. The incorporation of PEG with the tri-block (F6) caused a significant increase in the cytotoxicity of NPs in all of the three cancer cell lines. Block copolymer-based NPs can be considered as promising carriers for enhancing the efficacy of 5-FU in cancer therapy." @default.
• W2525304625 created "2016-10-07" @default.
• W2525304625 creator A5000692448 @default.
• W2525304625 creator A5007710835 @default.
• W2525304625 creator A5009480223 @default.
• W2525304625 creator A5026031583 @default.
• W2525304625 creator A5091506580 @default.
• W2525304625 date "2016-10-01" @default.
• W2525304625 modified "2023-10-16" @default.
• W2525304625 title "Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil" @default.
• W2525304625 cites W1862714180 @default.
• W2525304625 cites W1978117893 @default.
• W2525304625 cites W1982759704 @default.
• W2525304625 cites W1984418916 @default.
• W2525304625 cites W1984641232 @default.
• W2525304625 cites W1986269446 @default.
• W2525304625 cites W1987303550 @default.
• W2525304625 cites W1989195046 @default.
• W2525304625 cites W1998642701 @default.
• W2525304625 cites W2005271397 @default.
• W2525304625 cites W2007602097 @default.
• W2525304625 cites W2009805582 @default.
• W2525304625 cites W2012235333 @default.
• W2525304625 cites W2014766929 @default.
• W2525304625 cites W2023806031 @default.
• W2525304625 cites W2030581217 @default.
• W2525304625 cites W2031162287 @default.
• W2525304625 cites W2032369546 @default.
• W2525304625 cites W2032965857 @default.
• W2525304625 cites W2041525775 @default.
• W2525304625 cites W2042973822 @default.
• W2525304625 cites W2046574646 @default.
• W2525304625 cites W2047824475 @default.
• W2525304625 cites W2051305606 @default.
• W2525304625 cites W2053911682 @default.
• W2525304625 cites W2055042568 @default.
• W2525304625 cites W2056832429 @default.
• W2525304625 cites W2061113020 @default.
• W2525304625 cites W2064036692 @default.
• W2525304625 cites W2075543804 @default.
• W2525304625 cites W2076100235 @default.
• W2525304625 cites W2081914868 @default.
• W2525304625 cites W2082133834 @default.
• W2525304625 cites W2083096887 @default.
• W2525304625 cites W2086608828 @default.
• W2525304625 cites W2087032263 @default.
• W2525304625 cites W2092201559 @default.
• W2525304625 cites W2110233014 @default.
• W2525304625 cites W2150236873 @default.
• W2525304625 cites W2157976579 @default.
• W2525304625 cites W2163121767 @default.
• W2525304625 cites W2165365468 @default.
• W2525304625 cites W2238976895 @default.
• W2525304625 cites W2478832762 @default.
• W2525304625 cites W34706730 @default.
• W2525304625 cites W4252693198 @default.
• W2525304625 cites W2318707663 @default.
• W2525304625 doi "https://doi.org/10.1109/tnb.2016.2612340" @default.
• W2525304625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28114073" @default.
• W2525304625 hasPublicationYear "2016" @default.
• W2525304625 type Work @default.
• W2525304625 sameAs 2525304625 @default.
• W2525304625 citedByCount "11" @default.
• W2525304625 countsByYear W25253046252018 @default.
• W2525304625 countsByYear W25253046252019 @default.
• W2525304625 countsByYear W25253046252020 @default.
• W2525304625 countsByYear W25253046252021 @default.
• W2525304625 countsByYear W25253046252022 @default.
• W2525304625 countsByYear W25253046252023 @default.
• W2525304625 crossrefType "journal-article" @default.
• W2525304625 hasAuthorship W2525304625A5000692448 @default.
• W2525304625 hasAuthorship W2525304625A5007710835 @default.
• W2525304625 hasAuthorship W2525304625A5009480223 @default.
• W2525304625 hasAuthorship W2525304625A5026031583 @default.
• W2525304625 hasAuthorship W2525304625A5091506580 @default.
• W2525304625 hasConcept C109316439 @default.
• W2525304625 hasConcept C13245373 @default.
• W2525304625 hasConcept C13965031 @default.
• W2525304625 hasConcept C147789679 @default.
• W2525304625 hasConcept C155672457 @default.
• W2525304625 hasConcept C15920480 @default.
• W2525304625 hasConcept C159985019 @default.
• W2525304625 hasConcept C171250308 @default.
• W2525304625 hasConcept C185592680 @default.
• W2525304625 hasConcept C187530423 @default.
• W2525304625 hasConcept C192562407 @default.
• W2525304625 hasConcept C202751555 @default.
• W2525304625 hasConcept C2779820397 @default.
• W2525304625 hasConcept C2779868350 @default.
• W2525304625 hasConcept C2780165375 @default.
• W2525304625 hasConcept C2780783641 @default.
• W2525304625 hasConcept C2781162966 @default.
• W2525304625 hasConcept C521977710 @default.
• W2525304625 hasConcept C55493867 @default.
• W2525304625 hasConcept C86181022 @default.
• W2525304625 hasConceptScore W2525304625C109316439 @default.
• W2525304625 hasConceptScore W2525304625C13245373 @default.
• W2525304625 hasConceptScore W2525304625C13965031 @default.

• next